H. Attalla et al., 2-METHOXYESTRADIOL-INDUCED PHOSPHORYLATION OF BCL-2 - UNCOUPLING FROMJNK SAPK ACTIVATION/, Biochemical and biophysical research communications (Print), 247(3), 1998, pp. 616-619
The natural estrogen metabolite 2-methoxyestradiol (2ME) is anti-angio
genic in vivo and a strong growth inhibitor in vitro. The growth inhib
ition is due to mitotic arrest and apoptosis. These effects are remini
scent of those induced by taxol, and appear to be mediated by inhibiti
on of microtubule dynamics. Here we have studied the cellular response
to 2ME in regard to potential mediators of the observed cellular chan
ges. 2ME treatment increases the insoluble polymerized fraction of cel
lular tubulin similar to taxol, and in contrast to the microtubule dep
olymerizing drugs such as colcemid and vincristine. This stabilization
following 2ME treatment is accompanied by phosphorylation and inactiv
ation of Bcl-2 increasing gradually hom 2-24 hours. To study the pathw
ay leading to Bcl-2 phosphorylation we analyzed Raf-1 and JNK/SAPK kin
ases, both of which have been reported to be involved in Bcl-2 inactiv
ation. Our results indicate that Raf-1 is phosphorylated in response t
o 2ME, but this occurs later than Bcl-2 phosphorylation suggesting tha
t Raf-1 is not directly phosphorylating Bcl-2. JNK/SAPK was activated
rapidly after 2ME treatment. However, this activation was transient an
d returned to undetectable levels by 2 hours of treatment, demonstrati
ng that JNK/SAPK is not directly phosphorylating Bcl-2. Taken together
with previous results indicating that overexpression of JNK/SAPK lead
s to Bcl-2 phosphorylation, our results would support a model where JN
K/SAPK is indirectly phosphorylating Bcl-2. (C) 1998 Academic Press.